[Federal Register Volume 66, Number 239 (Wednesday, December 12, 2001)]
[Notices]
[Page 64267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-30669]



[[Page 64267]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:
    Name: Advisory Committee on Immunization Practices (ACIP) 
Teleconference.
    Time and Date: 3:30 p.m.-5:30 p.m., December 7, 2001.
    Place: Teleconference call will originate at the Centers for 
Disease Control and Prevention in Atlanta, Georgia.
    Status: Closed.
    Purpose: The Committee is charged with advising the Director, CDC, 
on the appropriate uses of immunizing agents. In addition, under 42 
U.S.C. 1396s, the Committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines.
    Matters to be Discussed: The teleconference will convene in closed 
session from 3:30 p.m. to 5 p.m. on December 7, 2001. The purpose of 
this closed session is to discuss the use of anthrax vaccine for 
persons exposed to B. anthracis in the United States. This 
teleconference will be closed to the public in accordance with 
provisions set forth in 5 U.S.C. 552b(c)(1), (7) and (9)(B), and the 
Determination of the Deputy Director for Management, CDC, pursuant to 
Pub. L. 92-463.

SUPPLEMENTARY INFORMATION: As provided under 5 U.S.C. 552b(e) and 41 
CFR 102-3.150(b), the public health urgency of this agency business 
requires that the meeting be held prior to the first available date for 
publication of this notice in the Federal Register.

CONTACT PERSON FOR MORE INFORMATION: Gloria A. Kovach, Program Analyst, 
Epidemiology and Surveillance Division, National Immunization Program, 
CDC, 1600 Clifton Road, NE, M/S E61, Atlanta, Georgia 30333. Telephone 
404/639-8096.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

    Dated: December 6, 2001.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 01-30669 Filed 12-11-01; 8:45 am]
BILLING CODE 4163-18-P